Literature DB >> 28248829

Epidemiology and Outcomes of Pediatric Multiple Organ Dysfunction Syndrome.

R Scott Watson1, Sheri S Crow, Mary E Hartman, Jacques Lacroix, Folafoluwa O Odetola.   

Abstract

OBJECTIVE: To summarize the epidemiology and outcomes of children with multiple organ dysfunction syndrome as part of the Eunice Kennedy Shriver National Institute of Child Health and Human Development multiple organ dysfunction syndrome workshop (March 26-27, 2015). DATA SOURCES: Literature review, research data, and expert opinion. STUDY SELECTION: Not applicable. DATA EXTRACTION: Moderated by an experienced expert from the field, issues relevant to the epidemiology and outcomes of children with multiple organ dysfunction syndrome were presented, discussed, and debated with a focus on identifying knowledge gaps and research priorities. DATA SYNTHESIS: Summary of presentations and discussion supported and supplemented by the relevant literature.
CONCLUSIONS: A full understanding the epidemiology and outcome of multiple organ dysfunction syndrome in children is limited by inconsistent definitions and populations studied. Nonetheless, pediatric multiple organ dysfunction syndrome is common among PICU patients, occurring in up to 57% depending on the population studied; sepsis remains its leading cause. Pediatric multiple organ dysfunction syndrome leads to considerable short-term morbidity and mortality. Long-term outcomes of multiple organ dysfunction syndrome in children have not been well studied; however, studies of adults and children with other critical illnesses suggest that the risk of long-term adverse sequelae is high. Characterization of the long-term outcomes of pediatric multiple organ dysfunction syndrome is crucial to identify opportunities for improved treatment and recovery strategies that will improve the quality of life of critically ill children and their families. The workshop identified important knowledge gaps and research priorities intended to promote the development of standard definitions and the identification of modifiable factors related to its occurrence and outcome.

Entities:  

Mesh:

Year:  2017        PMID: 28248829      PMCID: PMC5334773          DOI: 10.1097/PCC.0000000000001047

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  107 in total

1.  Multiple, progressive, or sequential systems failure. A syndrome of the 1970s.

Authors:  A E Baue
Journal:  Arch Surg       Date:  1975-07

2.  Clinical Outcomes Associated With RBC Transfusions in Critically Ill Children: A 1-Year Prospective Study.

Authors:  Pierre Demaret; Marisa Tucci; Oliver Karam; Helen Trottier; Thierry Ducruet; Jacques Lacroix
Journal:  Pediatr Crit Care Med       Date:  2015-07       Impact factor: 3.624

Review 3.  Health-related quality of life following pediatric critical illness.

Authors:  François Aspesberro; Rita Mangione-Smith; Jerry J Zimmerman
Journal:  Intensive Care Med       Date:  2015-04-08       Impact factor: 17.440

Review 4.  Outcome evaluations as measures of quality in pediatric intensive care.

Authors:  D H Fiser
Journal:  Pediatr Clin North Am       Date:  1994-12       Impact factor: 3.278

5.  Children with chronic illness return to their baseline functional status after organ dysfunction on the first day of admission in the pediatric intensive care unit.

Authors:  Katri V Typpo; Nancy J Petersen; Laura A Petersen; M Michele Mariscalco
Journal:  J Pediatr       Date:  2010-03-10       Impact factor: 4.406

6.  Neuropsychologic function three to six months following admission to the PICU with meningoencephalitis, sepsis, and other disorders: a prospective study of school-aged children.

Authors:  Lorraine C Als; Simon Nadel; Mehrengise Cooper; Christine M Pierce; Barbara J Sahakian; M Elena Garralda
Journal:  Crit Care Med       Date:  2013-04       Impact factor: 7.598

7.  Hemodynamic support in fluid-refractory pediatric septic shock.

Authors:  G Ceneviva; J A Paschall; F Maffei; J A Carcillo
Journal:  Pediatrics       Date:  1998-08       Impact factor: 7.124

8.  Long-term cognitive functioning in children and adolescents who survived septic shock caused by Neisseria meningitidis.

Authors:  L C A C Vermunt; C M P Buysse; F K Aarsen; C E Catsman-Berrevoets; H J Duivenvoorden; K F M Joosten; J A Hazelzet; F C Verhulst; E M W J Utens
Journal:  Br J Clin Psychol       Date:  2008-12-16

9.  Functional outcomes in pediatric severe sepsis: further analysis of the researching severe sepsis and organ dysfunction in children: a global perspective trial.

Authors:  Reid W D Farris; Noel S Weiss; Jerry J Zimmerman
Journal:  Pediatr Crit Care Med       Date:  2013-11       Impact factor: 3.624

10.  Epidemiology of sepsis and multiple organ dysfunction syndrome in children.

Authors:  F Proulx; M Fayon; C A Farrell; J Lacroix; M Gauthier
Journal:  Chest       Date:  1996-04       Impact factor: 9.410

View more
  31 in total

Review 1.  The intensive care medicine clinical research agenda in paediatrics.

Authors:  Mark J Peters; Andrew Argent; Marino Festa; Stéphane Leteurtre; Jefferson Piva; Ann Thompson; Douglas Willson; Pierre Tissières; Marisa Tucci; Jacques Lacroix
Journal:  Intensive Care Med       Date:  2017-03-17       Impact factor: 17.440

2.  Outcomes Associated With Multiple Organ Dysfunction Syndrome in Critically Ill Children With Hyperglycemia.

Authors:  Lauren E Marsillio; Lisa A Asaro; Vijay Srinivasan; David Wypij; Lauren R Sorce; Michael S D Agus; Vinay M Nadkarni
Journal:  Pediatr Crit Care Med       Date:  2019-12       Impact factor: 3.624

3.  Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.

Authors:  Samuel Dubinsky; Kevin Watt; Steven Saleeb; Bilal Ahmed; Caitlin Carter; Cindy H T Yeung; Andrea Edginton
Journal:  Clin Pharmacokinet       Date:  2021-11-30       Impact factor: 6.447

4.  AKI in COVID-19-Associated Multisystem Inflammatory Syndrome in Children (MIS-C).

Authors:  Marissa Lipton; Ruchi Mahajan; Catherine Kavanagh; Carol Shen; Ibrahim Batal; Samriti Dogra; Namrata G Jain; Fangming Lin; Natalie S Uy
Journal:  Kidney360       Date:  2021-02-03

5.  Impaired Lymphocyte Responses in Pediatric Sepsis Vary by Pathogen Type and are Associated with Features of Immunometabolic Dysregulation.

Authors:  Robert B Lindell; Donglan Zhang; Jenny Bush; Douglas C Wallace; Joshua D Rabinowitz; Wenyun Lu; E John Wherry; Scott L Weiss; Sarah E Henrickson
Journal:  Shock       Date:  2022-06-01       Impact factor: 3.533

6.  Does Non-Neurologic Multiorgan Dysfunction After Out-of-Hospital Cardiac Arrest among Children Admitted in Coma Predict Outcome 1 Year Later?

Authors:  Kelly L Corbett; Angela P Presson; Chong Zhang; Yizhe Xu; Susan L Bratton; Rebecca R Dixon
Journal:  J Pediatr Intensive Care       Date:  2020-09-11

7.  Outcomes Associated With Timing of Neurologic Dysfunction Onset Relative to Pediatric Sepsis Recognition.

Authors:  Alicia M Alcamo; Scott L Weiss; Julie C Fitzgerald; Matthew P Kirschen; Laura L Loftis; Swee Fong Tang; Neal J Thomas; Vinay M Nadkarni; Sholeen T Nett
Journal:  Pediatr Crit Care Med       Date:  2022-05-03       Impact factor: 3.971

8.  Outcomes of Day 1 Multiple Organ Dysfunction Syndrome in the PICU.

Authors:  Katri Typpo; R Scott Watson; Tellen D Bennett; Reid W D Farris; Michael C Spaeder; Nancy J Petersen
Journal:  Pediatr Crit Care Med       Date:  2019-10       Impact factor: 3.624

9.  Gastrointestinal Complications in Critically Ill Children: Experience from A Resource-Limited Country.

Authors:  Sidra Ishaque; Mariam Shakir; Asma Ladak; Anwar Ul Haque
Journal:  Pak J Med Sci       Date:  2021 May-Jun       Impact factor: 1.088

10.  Multidrug-resistant organisms: A significant cause of severe sepsis in pediatric intestinal and multi-visceral transplantation.

Authors:  Alicia M Alcamo; Mira K Trivedi; Carly Dulabon; Christopher M Horvat; Geoffrey J Bond; Joseph A Carcillo; Michael Green; Marian G Michaels; Rajesh K Aneja
Journal:  Am J Transplant       Date:  2021-07-28       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.